SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: geewiz who wrote (35)8/20/1997 11:12:00 AM
From: novice investor   of 534
 
Hi Art,

<I spoke to Peggy Miller this afternoon at IR. The registration
to sell an additional 3 million shares relates to the sale in
June which is discussed in the most recent release. This is not
an additional 3 million shares. >

Well, remember the following entry from my message #23?

===== from message # 23

The form S-3 was filed on 7/9 for the following amount:

---- from form S-3
Title of Shares Amount to be Proposed Maximum Proposed Maximum
to be Registered Registered (1) Offering Aggregate
Price Per Share Offering
(2) Price (2)

Common Stock 2,641,279 $0.765 $2,020,578.40
----

Note that the amount of shares increased from 1,744,186 (10-K) to
2,641,279 (S-3) and to 2.9 million (today's news).

======

The S-3 filed on August 4 is for 4 million shares and is for
a completely different price. Here are the details from 8/4
version of S-3:

----- from 8/4 version S-3

Title of Shares Amount to be Proposed Maximum Proposed Maximum
to be Registered Registered (1) Offering Aggregate
Price Per Share Offering
(2) Price (2)

Common Stock 4,385,467 $0.7528 $3,301,510.40

-----

Art, this is clearly a new filing with SEC! It may be classified
as an amendment to the July release of S-3 but if Peggy really
thinks this is one of previously reported items, well she is
grossly uninformed at best.

Last year I made fatal mistake of placing all of my retirement
fund into 2 high risk stocks. One was BJCT and the other was
a small chip maker called Telcom (TLCM@NASDAQ). When TLCM fell
below $4 in November I received a margin call (since I draw
living expenses the account went into margin last year).
At that time TLCM showed no future while BJCT still was waiting
for FDA approval to start the Shering contract; I sold all of
TLCM and converted all funds to BJCT.
As luck would have it I sold TLCM at the bottom while BJCT,
incredibly, still was not at its bottom. Since then TLCM has more
than recovered and is currently trading at around $14.

I made a very tough decision last week to come out of retirement
and also to make more emotionally correct investments. My analysis
indicates that I have been too optimistic on BJCT and it has cost
me my nestegg. I expect to be working as a management consultant
and mostly out of BJCT by September.

I still hope best for you and BJCT.

NI
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext